Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
214.50    -8.00 (-3.60%)
Bid:
211.00
Ask:
218.00
Spread: 7.00 (3.318%)
Market Cap: £146.53m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

PCA Shareholding

8 Apr 2022 07:00

RNS Number : 7187H
Helios Underwriting Plc
08 April 2022
Β 

Β 

Helios Underwriting plc

("Helios", "Company" or the "Group")

Β 

PCAs' ShareholdingsΒ 

Β 

Helios, the unique investment vehicle which acquires and consolidates underwriting capacity at Lloyd's,Β was informed yesterday that Elizabeth Hanbury, George Hanbury and Clementine Hanbury, each of whom are persons closely associated ("PCA") with Nigel Hanbury, Chief Executive Officer and person discharging managerial responsibilities ("PDMR") of the Company, have sold a number of ordinary shares of 10 pence each ("Ordinary Shares"), and subsequently repurchased the same number of Ordinary Shares into their respective Individual Savings Accounts (ISAs), in order to effect "Bed and ISA" trades. Details of these trades are as set out below:

Name

Position/status

No. of Ordinary Shares Sold

Sale price per Ordinary Share

No. of Ordinary Shares Repurchased

Purchase price per Ordinary Share

Elizabeth Hanbury

PCA

13,000

155p

13,000

155.07p

George Hanbury

PCA

13,000

155p

13,000

155.07p

Clementine Hanbury

PCA

13,000

155p

13,000

155.07p

Β 

Following the completion of the above transactions,Β Nigel Hanbury's ultimate beneficial ownership, including shares held by his immediate family members, is unchanged and remains at 9,549,794Β Ordinary Shares in total, representing approximately 13.62 per cent. of the Company's total voting rights.

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail on the transactions.

Β 

Β 

For further information please contact:

Β 

Helios Underwriting plc

Nigel Hanbury - Chief Executive +44 (0)7787 530 404 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer +44 (0)7754 965 917

Β 

Shore Capital (Nomad and Broker)

Robert Finlay +44 (0)20 7408 4080

David Coaten

Henry Willcocks

Β 

Willis Re Securities (Financial Adviser)

Alastair Rodger +44 (0)20 3124 6033

Quentin Perrot +44 (0)20 3124 6499

Β 

Buchanan

Helen Tarbet / Henry WilsonΒ / George Beale +44 (0)7872 604 453

+44 (0)20 7466 5111Β 

Β 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately Β£232m of capacity for the 2022 account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.Β 

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Β 

Elizabeth Hanbury

2

Reason for the notification

a)

Position/status

Β 

PCA of Nigel Hanbury

b)

Initial notification/Amendment

Β 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Helios Underwriting Plc

b)

LEI

213800FX86DJW5TCM864

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Β 

Identification code

Β Ordinary Shares of 10 pence each

Β 

ISIN - GB00B23XLS45

b)

Nature of the transaction

Β 

On market sale of Ordinary Shares and immediate repurchase by way of Bed and ISA arrangement

c)

Price(s) and volume(s)

Β Β Β 

Price(s)

Volume(s)

Sale: 155p

13,000

Purchase: 155.07p

13,000

Β 

d)

Aggregated information

Β 

Price(s)

Volume(s)

Sale: as above

Purchase: as above

As above

As above

Β 

e)

Date of the transaction

Β 

7 April 2022

f)

Place of the transactionΒ Β 

Β 

London Stock Exchange, AIM

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Β 

George Hanbury

2

Reason for the notification

a)

Position/status

Β 

PCA of Nigel Hanbury

b)

Initial notification/Amendment

Β 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Helios Underwriting Plc

b)

LEI

213800FX86DJW5TCM864

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Β 

Identification code

Β Ordinary Shares of 10 pence each

Β 

ISIN - GB00B23XLS45

b)

Nature of the transaction

Β 

On market sale of Ordinary Shares and immediate repurchase by way of Bed and ISA arrangement

c)

Price(s) and volume(s)

Β Β Β 

Price(s)

Volume(s)

Sale: 155p

13,000

Purchase: 155.07p

13,000

Β 

d)

Aggregated information

Β 

Price(s)

Volume(s)

Sale: as above

Purchase: as above

As above

As above

Β 

e)

Date of the transaction

Β 

7 April 2022

f)

Place of the transactionΒ Β 

Β 

London Stock Exchange, AIM

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Β 

Clementine Hanbury

2

Reason for the notification

a)

Position/status

Β 

PCA of Nigel Hanbury

b)

Initial notification/Amendment

Β 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Helios Underwriting Plc

b)

LEI

213800FX86DJW5TCM864

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Β 

Identification code

Β Ordinary Shares of 10 pence each

Β 

ISIN - GB00B23XLS45

b)

Nature of the transaction

Β 

On market sale of Ordinary Shares and immediate repurchase by way of Bed and ISA arrangement

c)

Price(s) and volume(s)

Β Β Β 

Price(s)

Volume(s)

Sale: 155p

13,000

Purchase: 155.07p

13,000

Β 

d)

Aggregated information

Β 

Price(s)

Volume(s)

Sale: as above

Purchase: as above

As above

As above

Β 

e)

Date of the transaction

Β 

7 April 2022

f)

Place of the transactionΒ Β 

Β 

London Stock Exchange, AIM

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHDDLFBLZLLBBL
Date   Source Headline
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSFinal Results for the year ended 31 December 2025
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTR-1 announcement
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTR-1: Acquisition of Voting Rights
21st Apr 20267:00 amRNSChange of Nominated Adviser
20th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20265:17 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSQuarterly Syndicate Mid-point Forecast update
20th Jan 20267:00 amRNS2026 YOA Portfolio Update
9th Jan 20267:00 amRNSAppointment of Chief Underwriting Officer
4th Dec 20255:42 pmRNSGrant of LTIP Awards
2nd Dec 20257:00 amRNSNet Asset Value(s)
13th Nov 20251:32 pmRNSDirector/PDMR Shareholding
13th Nov 20251:30 pmRNSDirector/PDMR Shareholding
7th Nov 202510:10 amRNSHolding(s) in Company
6th Nov 20251:51 pmRNSDirector/PDMR Shareholding
5th Nov 20255:48 pmRNSTR1 - Change in breakdown of voting rights
30th Oct 20257:00 amRNSResult of Tender Offer
24th Oct 202512:20 pmRNSResults of General Meeting
21st Oct 20257:01 amRNSDirector Appointments
21st Oct 20257:00 amRNSCapital Markets Day
29th Sep 20257:01 amRNSProposed Tender Offer and Notice of GM
29th Sep 20257:00 amRNSHalf Year Results
19th Sep 20257:00 amRNSAppointment of Chief Executive Officer
1st Sep 20253:37 pmRNSDirector/PDMR Shareholding
29th Aug 202512:52 pmRNSPDMR Dealing
28th Aug 20252:16 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSQuarterly Syndicate Mid-point Forecasts
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 202512:12 pmRNSTR-1: Notification of major holdings
18th Jul 20257:00 amRNSResults of Scrip Dividend Election
9th Jul 20259:45 amRNSResults of Scrip Dividend Election
30th Jun 20255:40 pmRNSAppointment of Executive Director
30th Jun 202512:28 pmRNSResult of AGM
30th Jun 20257:00 amRNSChange of Nominated Adviser
20th Jun 20259:32 amRNSScrip Dividend Reference Price
9th Jun 20251:15 pmRNSLTIP Exercise and Total Voting Rights Update
9th Jun 20251:15 pmRNSGrant of LTIP Awards
2nd Jun 20257:00 amRNSPosting of Annual Report and Notice of AGM
2nd Jun 20257:00 amRNSFinal results for the year ended 31 December 2024
29th May 20257:06 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.